{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T19:21:32Z","timestamp":1787772092730,"version":"build-2784847793"},"reference-count":27,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,1]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n                  <jats:sec>\n                    <jats:title>PURPOSE:<\/jats:title>\n                    <jats:p>The purpose of this study is to evaluate the visual response of methanol-induced optic neuropathy to management with erythropoietin (EPO) along with conventional therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>METHODS:<\/jats:title>\n                    <jats:p>This retrospective case series examines the ophthalmological data of patients diagnosed with methanol-induced optic neuropathy between 2020 and 2021 at two centers, Riyadh, Saudi Arabia. Patients\u2019 characteristics and the results of initial and final ophthalmological examinations were documented and compared between patients who received EPO in addition to conventional management and those who received only conventional management.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>RESULTS:<\/jats:title>\n                    <jats:p>A total of nine cases were reviewed, of which eight (88.9%) were males and one was female (11.1%). The mean age was 37.7 years. At presentation, funduscopic examination revealed optic disc edema in four eyes (two patients), and 14 eyes had normal appearance (seven patients). Among the nine patients who received conventional management, 5 (55.6%) additionally received intravenous EPO during the treatment course. There was no clinically or statistically significant difference in terms of visual outcome between the two groups. The mean visual acuity at the final presentation was 1.32 \u00b1 0.79 logarithm of the minimum angle of resolution (LogMAR) in the EPO group and 1.36 \u00b1 0.85 LogMAR in the non-EPO group. Optical coherence tomography indicated that the EPO group had an average retinal nerve fiber layer thickness of 48.13\u03bcm (\u00b16.2), at the final assessment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>CONCLUSION:<\/jats:title>\n                    <jats:p>Managing the visual impairments in individuals with methanol-induced optic neuropathy using intravenous EPO resulted in similar final visual outcomes compared to conventional management.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.4103\/sjopt.sjopt_174_22","type":"journal-article","created":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T13:00:28Z","timestamp":1711717228000},"page":"41-46","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Visual outcome of methanol toxic optic neuropathy after erythropoietin treatment in Riyadh, Saudi Arabia"],"prefix":"10.4103","volume":"38","author":[{"given":"Malek","family":"Alrobaian","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Ministry of the National Guard \u2013 Health Affairs, Riyadh, Saudi Arabia"},{"name":"King Abdullah International Medical Research Center, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arwa","family":"Alkhuraiji","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Ministry of the National Guard \u2013 Health Affairs, Riyadh, Saudi Arabia"},{"name":"King Abdullah International Medical Research Center, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rema","family":"Almohanna","sequence":"additional","affiliation":[{"name":"King Abdullah International Medical Research Center, Riyadh, Saudi Arabia"},{"name":"Department of Surgery, Ministry of the National Guard \u2013 Health Affairs, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammed","family":"Alshehri","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, King Khalid University Hospital, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bader","family":"Alyahya","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, College of Medicine, King Saud University, Riyadh, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2023,7,15]]},"reference":[{"key":"R1-20240830","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/BF03259846","article-title":"Methanol and ethylene glycol poisonings. Mechanism of toxicity, clinical course, diagnosis and treatment","volume":"1","author":"Jacobsen","year":"1986","journal-title":"Med Toxicol"},{"key":"R2-20240830","doi-asserted-by":"crossref","first-page":"e0152676","DOI":"10.1371\/journal.pone.0152676","article-title":"The methanol poisoning outbreaks in Libya 2013 and Kenya 2014","volume":"11","author":"Rostrup","year":"2016","journal-title":"PLoS One"},{"key":"R3-20240830","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.alcohol.2020.07.002","article-title":"Methanol poisoning in Turkey:Two outbreaks, a single Center experience","volume":"88","author":"Gulen","year":"2020","journal-title":"Alcohol"},{"key":"R4-20240830","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.cardiores.2006.07.001","article-title":"Beyond erythropoiesis:The anti-inflammatory effects of erythropoietin","volume":"71","author":"Feng","year":"2006","journal-title":"Cardiovasc Res"},{"key":"R5-20240830","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1167\/iovs.03-1039","article-title":"Effect of erythropoietin axotomy-induced apoptosis in rat retinal ganglion cells","volume":"45","author":"Weishaupt","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R6-20240830","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.surneu.2008.02.040","article-title":"Erythropoietin as a neuroprotective agent in traumatic brain injury Review","volume":"71","author":"Mammis","year":"2009","journal-title":"Surg Neurol"},{"key":"R7-20240830","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.2174\/1871527314666150821104800","article-title":"Therapeutic potential of erythropoietin in retinal and optic nerve diseases","volume":"14","author":"Kucuk","year":"2015","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"R8-20240830","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00347-009-2030-1","article-title":"Erythropoietin protects retinal ganglion cells and visual function after ocular ischemia and optic nerve compression","volume":"107","author":"Jehle","year":"2010","journal-title":"Ophthalmologe"},{"key":"R9-20240830","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.expneurol.2007.01.017","article-title":"Erythropoietin is both neuroprotective and neuroregenerative following optic nerve transection","volume":"205","author":"King","year":"2007","journal-title":"Exp Neurol"},{"key":"R10-20240830","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.joco.2016.01.008","article-title":"Erythropoietin in ophthalmology:A literature review","volume":"28","author":"Abri Aghdam","year":"2016","journal-title":"J Curr Ophthalmol"},{"key":"R11-20240830","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s10792-017-0553-z","article-title":"Intravitreal erythropoietin injection in late-stage optic neuropathy:A safety study on human","volume":"38","author":"Acar","year":"2018","journal-title":"Int Ophthalmol"},{"key":"R12-20240830","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1097\/WNO.0b013e318262a7c2","article-title":"Erythropoietin treatment for methanol optic neuropathy","volume":"32","author":"Pakravan","year":"2012","journal-title":"J Neuroophthalmol"},{"key":"R13-20240830","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1001\/archopht.1977.04450100149021","article-title":"Methyl alcohol poisoning. II. Development of a model for ocular toxicity in methyl alcohol poisoning using the rhesus monkey","volume":"95","author":"Martin-Amat","year":"1977","journal-title":"Arch Ophthalmol"},{"key":"R14-20240830","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1212\/WNL.32.10.1093","article-title":"Methanol optic neuropathy:A histopathological study","volume":"32","author":"Sharpe","year":"1982","journal-title":"Neurology"},{"key":"R15-20240830","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1080\/713857189","article-title":"Toxicological and metabolic consequences of methanol poisoning","volume":"13","author":"Skrzydlewska","year":"2003","journal-title":"Toxicol Mech Methods"},{"key":"R16-20240830","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s00706-015-1581-x","article-title":"Factors predicting optic nerve axonal degeneration after methanol-induced acute optic neuropathy:A 2-year prospective study in 54 patients","volume":"147","author":"Zakharov","year":"2015","journal-title":"Monatsh Chem"},{"key":"R17-20240830","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1136\/bjo.2003.027664","article-title":"The distributions of mitochondria and sodium channels reflect the specific energy requirements and conduction properties of the human optic nerve head","volume":"88","author":"Barron","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"R18-20240830","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/0002-9343(80)90113-8","article-title":"Methanol poisoning in human subjects. Role for formic acid accumulation in the metabolic acidosis","volume":"68","author":"McMartin","year":"1980","journal-title":"Am J Med"},{"key":"R19-20240830","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3109\/15563650.2011.556642","article-title":"Outcomes of visual disturbances after methanol poisoning","volume":"49","author":"Sanaei-Zadeh","year":"2011","journal-title":"Clin Toxicol (Phila)"},{"key":"R20-20240830","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1097\/OPX.0b013e31823ee128","article-title":"Methanol poisoning:Ocular and neurological manifestations","volume":"89","author":"Sharma","year":"2012","journal-title":"Optom Vis Sci"},{"key":"R21-20240830","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/WNO.0000000000000614","article-title":"Erythropoietin in treatment of methanol optic neuropathy","volume":"38","author":"Pakdel","year":"2018","journal-title":"J Neuroophthalmol"},{"key":"R22-20240830","doi-asserted-by":"crossref","first-page":"797","DOI":"10.3109\/15563650.2015.1059946","article-title":"Fomepizole versus ethanol in the treatment of acute methanol poisoning:Comparison of clinical effectiveness in a mass poisoning outbreak","volume":"53","author":"Zakharov","year":"2015","journal-title":"Clin Toxicol (Phila)"},{"key":"R23-20240830","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jab.2014.04.001","article-title":"Acute methanol poisonings:Folates administration and visual sequelae","volume":"12","author":"Zakharov","year":"2014","journal-title":"J Appl Biomed"},{"key":"R24-20240830","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1097\/CCM.0000000000000708","article-title":"Recommendations for the role of extracorporeal treatments in the management of acute methanol poisoning:A systematic review and consensus statement","volume":"43","author":"Roberts","year":"2015","journal-title":"Crit Care Med"},{"key":"R25-20240830","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1038\/sj.ki.5002482","article-title":"Antioxidative effects of erythropoietin","volume":"27","author":"Katavetin","year":"2007","journal-title":"Kidney Int Suppl"},{"key":"R26-20240830","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1080\/15569527.2017.1373121","article-title":"Evaluation of the effect of erythropoietin + corticosteroid versus corticosteroid alone in methanol-induced optic nerve neuropathy","volume":"37","author":"Zamani","year":"2018","journal-title":"Cutan Ocul Toxicol"},{"key":"R27-20240830","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s10384-005-0311-z","article-title":"Methanol-induced retinal toxicity patient examined by optical coherence tomography","volume":"50","author":"Fujihara","year":"2006","journal-title":"Jpn J Ophthalmol"}],"container-title":["Saudi Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/sjopt.sjopt_174_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T18:28:03Z","timestamp":1787768883000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/sjopt.sjopt_174_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,15]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.4103\/sjopt.sjopt_174_22","relation":{},"ISSN":["1319-4534","2542-6680"],"issn-type":[{"value":"1319-4534","type":"print"},{"value":"2542-6680","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,15]]},"assertion":[{"value":"2022-10-04","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-03-07","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}